OptimizeRx CorporationOPRXNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank69
3Y CAGR-7.9%
5Y CAGR-15.9%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-7.9%/yr
Quarterly compound
5Y CAGR
-15.9%/yr
Recent acceleration
Percentile
P69
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202523.68%
Q3 2025-10.71%
Q2 202533.14%
Q1 2025-32.15%
Q4 202451.65%
Q3 202413.27%
Q2 2024-4.46%
Q1 2024-30.59%
Q4 202373.71%
Q3 202318.19%
Q2 20236.27%
Q1 2023-33.84%
Q4 202230.29%
Q3 20227.92%
Q2 20221.80%
Q1 2022-32.40%
Q4 202125.97%
Q3 202118.34%
Q2 202121.34%
Q1 2021-31.64%
Q4 202056.16%
Q3 202019.76%
Q2 202015.80%
Q1 20202.78%
Q4 201947.51%
Q3 2019-28.60%
Q2 201934.49%
Q1 2019-20.82%
Q4 201821.49%
Q3 20186.19%
Q2 201824.01%
Q1 20182.63%
Q4 201729.15%
Q3 20178.26%
Q2 201733.17%
Q1 2017-6.13%
Q4 201628.35%
Q3 2016-6.65%
Q2 20168.74%
Q1 2016-12.91%